Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 02, 2019

SELL
$26.93 - $34.7 $6.15 Million - $7.92 Million
-228,220 Closed
0 $0
Q3 2018

Oct 31, 2018

SELL
$37.57 - $50.34 $8.57 Million - $11.5 Million
-228,220 Reduced 50.0%
228,220 $10.5 Million
Q3 2018

Oct 25, 2018

BUY
$37.57 - $50.34 $8.57 Million - $11.5 Million
228,220 Added 100.0%
456,440 $19 Million
Q1 2018

May 07, 2018

BUY
$28.83 - $41.01 $1.56 Million - $2.22 Million
54,122 Added 31.09%
228,220 $6.74 Million
Q4 2017

Jan 25, 2018

BUY
$28.45 - $37.14 $4.95 Million - $6.47 Million
174,098
174,098 $5.98 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.